Effects of multi-ion beams in combination with sotorasib on KRAS G12C mutant pancreatic cancer cells

被引：0
|
作者：
Sai, Sei [1 ]
Kang, Yumei [2 ,3 ]
Suzuki, Masao [1 ]
Yamada, Shigeru [2 ]
Koto, Masashi [1 ,2 ]
机构：
[1] QST, Dept Charg Part Ther Res, Chiba, Japan
[2] QST Hosp, Chiba, Japan
[3] Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-3026
引用
收藏
页码：1592 / 1592
页数：1
相关论文
共 50 条
  • [21] Small Molecule Imaging Agent for Mutant KRAS G12C
    Koch, Peter D.
    Quintana, Jeremy
    Ahmed, Maaz S.
    Kohler, Rainer H.
    Weissleder, Ralph
    ADVANCED THERAPEUTICS, 2021, 4 (05)
  • [22] Impact of a High-Fat Meal on the Pharmacokinetics of Sotorasib, a KRAS G12C Inhibitor
    Cardona, Panli
    Dutta, Sandeep
    Houk, Brett
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (11): : 1219 - 1226
  • [23] A case of hepatoid adenocarcinoma of the lung harboring KRAS G12C responded favorably to sotorasib
    Uruga, Hironori
    Miyamoto, Atsushi
    Fujii, Takeshi
    Okuma, Takashi
    Mitsumura, Takahiro
    Tamaoka, Meiyo
    Takazawa, Yutaka
    PATHOLOGY INTERNATIONAL, 2024, 74 (09) : 546 - 551
  • [24] Use of sotorasib in KRAS p. G12C mutated NSCLC: a case report
    Barot, Hasti
    Evans, Joanne
    Mohammed, Waleed
    Power, Danielle
    LUNG CANCER, 2022, 165 : S77 - S77
  • [25] Sotorasib: A Review in KRAS G12C Mutation-Positive Non-small Cell Lung Cancer
    Arnold Lee
    Targeted Oncology, 2022, 17 : 727 - 733
  • [26] A Phase 1B Trial of Tarloxotinib and Sotorasib in Lung Cancer Patients with KRAS G12C Mutations
    Alexander, M.
    Tirunagaru, V. G.
    Doebele, R. C.
    Wrangle, J. M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S361 - S361
  • [27] Establishment of KRAS G12C mutated colorectal cancer cells and drug screening for the combination therapy.
    Maruyama, Kohei
    Shimizu, Yuki
    Oh-hara, Tomoko
    Nagayama, Satoshi
    Fujita, Naoya
    Katayama, Ryohei
    CANCER SCIENCE, 2021, 112 : 799 - 799
  • [28] FGTI-2734 Inhibits ERK Reactivation to Overcome Sotorasib Resistance in KRAS G12C Lung Cancer
    Kazi, Aslamuzzaman
    Vasiyani, Hitesh
    Ghosh, Deblina
    Bandyopadhyay, Dipankar
    Shah, Rachit D.
    Vudatha, Vignesh
    Trevino, Jose
    Sebti, Said M.
    JOURNAL OF THORACIC ONCOLOGY, 2025, 20 (03) : 331 - 344
  • [29] Sotorasib GTPase KRAS (G12C mutant) inhibitor Treatment of non-small cell lung cancer Treatment of colorectal cancer Treatment of solid tumors
    Gras, J.
    DRUGS OF THE FUTURE, 2021, 46 (07) : 521 - 528
  • [30] Sotorasib: A Review in KRAS G12C Mutation-Positive Non-small Cell Lung Cancer
    Lee, Arnold
    TARGETED ONCOLOGY, 2022, 17 (06) : 727 - 733
12345